New drugs for rheumatoid arthritis, N Engl J Med, vol.350, pp.2167-2179, 2004. ,
Adalimumab, BioDrugs, vol.16, issue.2, pp.121-139, 2004. ,
DOI : 10.2165/00063030-200418020-00005
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial, Arthritis & Rheumatism, vol.44, issue.11, pp.3230-3236, 2003. ,
DOI : 10.1002/art.11325
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial, The Lancet, vol.359, issue.9317, pp.1541-1549, 2002. ,
DOI : 10.1016/S0140-6736(02)08512-4
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor ?? for Crohn's Disease, New England Journal of Medicine, vol.337, issue.15, pp.1029-1035, 1997. ,
DOI : 10.1056/NEJM199710093371502
TNF?? therapy in psoriatic arthritis and psoriasis, Annals of the Rheumatic Diseases, vol.63, issue.7, pp.755-758, 2004. ,
DOI : 10.1136/ard.2004.020719
Etanercept as Monotherapy in Patients with Psoriasis, New England Journal of Medicine, vol.349, issue.21, pp.2014-2022, 2003. ,
DOI : 10.1056/NEJMoa030409
Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study, Annals of the Rheumatic Diseases, vol.62, issue.3, pp.245-247, 2003. ,
DOI : 10.1136/ard.62.3.245
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor ?????Neutralizing Agent, New England Journal of Medicine, vol.345, issue.15, pp.1098-1104, 2001. ,
DOI : 10.1056/NEJMoa011110
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report, Arthritis & Rheumatism, vol.44, issue.Suppl 9, pp.2122-2127, 2003. ,
DOI : 10.1002/art.11137
Infections and anti-tumor necrosis factor ? therapy, Arthritis & Rheumatism, vol.46, issue.11, pp.3013-3022, 2003. ,
DOI : 10.1002/art.11301
Granulomatous Infections Due to Tumor Necrosis Factor Blockade: Correction, Clinical Infectious Diseases, vol.39, issue.8, pp.1254-1255, 2004. ,
DOI : 10.1086/424455
URL : http://cid.oxfordjournals.org/cgi/content/short/39/8/1254
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden, Arthritis & Rheumatism, vol.63, issue.7, pp.1986-1992, 2005. ,
DOI : 10.1002/art.21137
The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation, Journal of Experimental Medicine, vol.177, issue.6, pp.1575-1585, 1993. ,
DOI : 10.1084/jem.177.6.1575
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn???s disease, Gastroenterology, vol.124, issue.7, pp.1774-1785, 2003. ,
DOI : 10.1016/S0016-5085(03)00382-2
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway, Gastroenterology, vol.121, issue.5, pp.1145-1157, 2001. ,
DOI : 10.1053/gast.2001.28702
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection, Cell, vol.56, issue.5, pp.731-740, 1989. ,
DOI : 10.1016/0092-8674(89)90676-4
Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factoralpha-deficient mice, Lab Invest, vol.79, pp.379-386, 1999. ,
Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance to Mycobacterium bovis Bacillus Calmette-Guerin Infection in the Absence of Secreted TNF and Lymphotoxin-??, The Journal of Immunology, vol.168, issue.7, pp.3394-3401, 2002. ,
DOI : 10.4049/jimmunol.168.7.3394
Reactivation of Latent Tuberculosis Infection in TNF-Deficient Mice, The Journal of Immunology, vol.171, issue.6, pp.3110-3118, 2003. ,
DOI : 10.4049/jimmunol.171.6.3110
infection, Clinical & Experimental Immunology, vol.82, issue.2, pp.279-287, 2004. ,
DOI : 10.1111/j.1365-2249.2004.02518.x
URL : https://hal.archives-ouvertes.fr/hal-01068720
Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection, The Journal of Immunology, vol.174, issue.8, pp.4852-4859, 2005. ,
DOI : 10.4049/jimmunol.174.8.4852
French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers, Annals of the Rheumatic Diseases, vol.62, issue.8, pp.791-792, 2003. ,
DOI : 10.1136/ard.62.8.791
Tuberculosis associated with therapy against tumor necrosis factor ??, Arthritis & Rheumatism, vol.52, issue.10, pp.2968-2974, 2005. ,
DOI : 10.1002/art.21382
Specific immune-based diagnosis of tuberculosis, The Lancet, vol.356, issue.9235, pp.1099-1104, 2000. ,
DOI : 10.1016/S0140-6736(00)02742-2
Detection of Active Tuberculosis Infection by T Cell Responses to Early???Secreted Antigenic Target 6???kDa Protein and Culture Filtrate Protein 10, The Journal of Infectious Diseases, vol.181, issue.5, pp.1850-1854, 2000. ,
DOI : 10.1086/315448
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells, The Lancet, vol.357, issue.9273, pp.2017-2021, 2001. ,
DOI : 10.1016/S0140-6736(00)05115-1
A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements, Thorax, vol.57, issue.9, pp.804-809, 2002. ,
DOI : 10.1136/thorax.57.9.804
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak, The Lancet, vol.361, issue.9364, pp.1168-1173, 2003. ,
DOI : 10.1016/S0140-6736(03)12950-9
Specific T-Cell Epitopes for Immunoassay-Based Diagnosis of Mycobacterium tuberculosis Infection, Journal of Clinical Microbiology, vol.42, issue.6, pp.2379-2387, 2004. ,
DOI : 10.1128/JCM.42.6.2379-2387.2004
Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.1, pp.65-69, 2004. ,
DOI : 10.1164/rccm.200402-232OC
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis, Infect Immun, vol.66, pp.717-723, 1998. ,
A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP- 10). Microbiology, pp.3195-3203, 1998. ,
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection, AIDS, vol.17, issue.3, pp.343-351, 2003. ,
DOI : 10.1097/00002030-200302140-00008
Evaluation of CD4+ T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometry, Clinical and Experimental Immunology, vol.91, issue.1, pp.76-80, 2003. ,
DOI : 10.1046/j.1365-2222.2002.01281.x
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.23, issue.2, pp.353-363, 2004. ,
DOI : 10.1002/art.20019
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.49, issue.6, pp.1451-1459, 2002. ,
DOI : 10.1002/art.10302
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors, Annals of the Rheumatic Diseases, vol.60, issue.2, pp.133-139, 2001. ,
DOI : 10.1136/ard.60.2.133
Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis, Annals of the Rheumatic Diseases, vol.64, issue.9, pp.1360-1361, 2005. ,
DOI : 10.1136/ard.2004.029041
Pilot Study of Tuberculosis Screening Strategies for Rheumatoid Arthritis Patients [abstract], Arthritis Rheum, vol.52, p.545, 2005. ,
The impact of steroid use on mantoux testing in patients undergoing screening for anti-TNF medication [abstract], Arthritis Rheum, vol.52, p.569, 2005. ,
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab, Arthritis & Rheumatism, vol.345, issue.3, pp.780-790, 2003. ,
DOI : 10.1002/art.10847
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis, Clinical and Experimental Immunology, vol.168, issue.2, pp.372-380, 2005. ,
DOI : 10.1093/emboj/18.8.2119
: Function, Generation, and Maintenance, Annual Review of Immunology, vol.22, issue.1, pp.745-763, 2004. ,
DOI : 10.1146/annurev.immunol.22.012703.104702
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report, Arthritis & Rheumatism, vol.53, issue.1, pp.61-72, 2005. ,
DOI : 10.1002/art.20764
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-??, Gastroenterology, vol.128, issue.2, pp.376-392, 2005. ,
DOI : 10.1053/j.gastro.2004.11.060
Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes, Cytokine, vol.28, issue.2, pp.67-74, 2004. ,
DOI : 10.1016/j.cyto.2004.06.008